Abcam, ab267262, Human UCK1 (UCK) knockout HEK-293T cell line

Size: 2 x 1000000Cells / vial / 1000000Cells / vial
UCK1 KO cell line available to order. KO validated by. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 1 and 1 bp deletion in exon 1. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.
Key facts
Cell type:HEK-293T,
Species or organism:Human,
Tissue:Kidney,
Form:LiquidSee storage information,
Knockout validation:Sanger Sequencing,
Mutation description:Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 1 and 1 bp deletion in exon 1

Product details:
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-UCK1, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Uridine-cytidine kinase (UCK) also known as uridine monophosphate kinase catalyzes the phosphorylation of uridine and cytidine to form uridine monophosphate (UMP) and cytidine monophosphate (CMP) respectively. This enzyme weighs about 30 kilodaltons. UCK expresses mostly in the cytoplasm with notable activity in tissues like the liver pancreas and kidney. Its function hinges on its ability to regulate nucleotide levels which are essential for nucleic acid metabolism.
Biological function summary
Uridine-cytidine kinase supports nucleotide homeostasis in cells. It does not form part of a larger enzymatic complex. This enzyme facilitates the salvage pathway converting nucleosides back into nucleotides. Such activity ensures sufficient nucleotide precursors for DNA and RNA synthesis which is critical during cell division and repair. Therefore disruptions in UCK function can severely impact cellular metabolism and proliferation.
Pathways
Nucleoside and nucleotide metabolism are key areas where uridine-cytidine kinase plays a prominent role. It particularly influences the pyrimidine salvage pathway an important process that helps recycle nucleotides within the cell. UCK interacts with other enzymes such as cytidine monophosphate kinase (CMP kinase) which further phosphorylates CMP into cytidine diphosphate (CDP). Proper functioning of these pathways ensures cellular nucleotide balance and genome integrity.
Abnormalities in uridine-cytidine kinase activity link to certain cancers and metabolic disorders. For example altered UCK activity has connections to cancer types where fast-proliferating cells show increased demand for nucleotides. Furthermore UCK changes have been associated with mitochondrial neurogastrointestinal encephalopathy (MNGIE). This disorder connects with dysfunctional thymidine phosphorylase highlighting the importance of nucleotide metabolism coordination. These insights help target UCK in therapeutic strategies for such diseases.